𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Perspectives and potential applications of nanomedicine in breast and prostate cancer

✍ Scribed by Yang Liu; Metasebya Solomon; Samuel Achilefu

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
559 KB
Volume
33
Category
Article
ISSN
0198-6325

No coin nor oath required. For personal study only.

✦ Synopsis

Nanomedicine is a branch of nanotechnology that includes the development of nanostructures and nanoanalytical systems for various medical applications. Among these applications, utilization of nanotechnology in oncology has captivated the attention of many research endeavors in recent years. The rapid development of nano‐oncology raises new possibilities in cancer diagnosis and treatment. It also holds great promise for realization of point‐of‐care, theranostics, and personalized medicine. In this article, we review advances in nano‐oncology, with an emphasis on breast and prostate cancer because these organs are amenable to the translation of nanomedicine from small animals to humans. As new drugs are developed, the incorporation of nanotechnology approaches into medicinal research becomes critical. Diverse aspects of nano‐oncology are discussed, including nanocarriers, targeting strategies, nanodevices, as well as nanomedical diagnostics, therapeutics, and safety. The review concludes by identifying some limitations and future perspectives of nano‐oncology in breast and prostate cancer management. Β© 2010 Wiley Periodicals, Inc. Med Res Rev

πŸ“œ SIMILAR VOLUMES

Cimetidine Use and Risk of Breast, Prost
Cimetidine Use and Risk of Breast, Prostate, and Other Cancers
✍ Laurel A Habel; Theodore R Levin; Gary D Friedman πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

Purpose - The study was conducted to examine whether use of cimetidine is associated with the risk of cancer, with special attention to cancers of the breast and prostate because cimetidine increases estradiol levels and interferes with androgen binding. Methods - Individuals who received a prescrip

Risk of prostate, breast and colorectal
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis
✍ Fabio Levi; Lalao Randimbison; Van-Cong Te; Manuela Maspoli Conconi; Carlo La Ve πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 64 KB πŸ‘ 1 views

## Abstract Ultraviolet radiation is the major cause of skin cancer, but promotes vitamin D synthesis, and vitamin D has been inversely related to the risk of several common cancers including prostate, breast and colorectum. We therefore computed the incidence of prostate, breast and colorectal can

Response: Risk of prostate, breast and c
Response: Risk of prostate, breast and colorectal cancer after skin cancer diagnosis
✍ Isabelle Soerjomataram; Esther de Vries πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 48 KB πŸ‘ 1 views

## Dear Sir, Recently, Levi et al. 1 reported the risks of developing a prostate, breast or colorectal cancer after an initial skin cancer diagnosis. The hypothesis was that skin cancer patients would have higher vitamin D levels through higher sun exposure and would, therefore, be at reduced risk